VEI 0.00% $1.07 vision eye institute limited

medical centre margins - pry, page-3

  1. 1,032 Posts.
    lightbulb Created with Sketch. 27
    VEI's growth strategy is likely to be led by surgery practice income rather than earnings generated from the company's 35% share of personal exertion efforts of its doctor doctors. The segment information is not split out in Vision's results, however the company has at various times reinforced the strong profitability of this segment of the business, which highlights that it is pivotal for them. PRY's segment results support the view of good prospects in this part of the medical services sector. It's in the executive's hands to execute on the strategy successfully! The capital raising in Jan repaid debt and provided some funding capacity to assist in this regard. Let's see what they update the market with later this month. There was a recent addition of a new UK recruit doctor partner A Ioannidis in the Victorian business, which was (unusually) not ASX announced; see the company's website.
 
watchlist Created with Sketch. Add VEI (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.